Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis
The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Abstract
T-cell types are important in maintaining immune homeostasis in the lung and their imbalance may be associated with several diseases. We examined the relationship between bronchoalveolar lavage (BAL) T-cell subset profiles and the clinical course of 46 patients with idiopathic pulmonary fibrosis (IPF). A flow cytometry cell sorter (FACS) was used to analyse the T-cell subsets. Pulmonary function tests (PFT) were performed at baseline and 6-12 months later. Patients were divided into two groups according to their CD4/CD8 ratio: CD4/CD8 >1 (group 1, n=21); and CD4/CD8 <1 (group 2, n=25). A lower percentage of lymphocytes, a higher percentage of CD8/S6F1 cells (cytotoxic T-lymphocytes) and a higher percentage of neutrophils were found in the BAL in group 2 compared to group 1 (11+/-7.5% versus 19+/-13.2%; p=0.024 and 29.8+/-17.6% versus 13.3+/-6.9%; p=0.068, respectively for lymphocytes and cytotoxic T-lymphocytes; and 8+/-11% versus 29+/-27%; p=0.003 for neutrophils). Inversely, in the peripheral blood, the distribution of CD8/S6F1 cells was lower in group 1 than in group 2 (8.3+/-6.9% versus 33.4+/-16.5%; p=0.0048). The patients were followed over a period of 1 yr in order to test whether those findings could determine efficacy of therapy. The baseline transfer factor of the lung for carbon monoxide (TL,CO) capacity in group 1 and group 2 was 59+/-22% and 51+/-21%, respectively (p=0.29), but only in group 1 was the TL,CO capacity improved significantly in response to steroids treatment after 6-12 months. IPF patients with a higher percentage of lymphocytes, a lower percentage of neutrophils, CD4/CD8 >1 and a low percentage of CD8/S6F1 may have a more benign course of disease. These parameters may identify an early stage of reversible disease responsive to therapy. We conclude that these measurements may be a useful tool in monitoring response to treatment in patients with idiopathic pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Relative to samples obtained from normal individuals, lung tissue and BAL fluid from patients with IPF are enriched for several population of T lymphocytes (126).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [126]
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Spagnolo, P., Rossi, G., Trisolini, R., Sverzellati, N., Baughman, R. P., & Wells, A. U. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30064-x · Cited by 949
American thoracic society statement: occupational contribution to the burden of airway disease
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.5.787 · Cited by 874
Regulation of the Immune Response — Inducer and Suppressor T-Lymphocyte Subsets in Human Beings
Reinherz, E. L., & Schlossman, S. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008143030704 · Cited by 724
Reynolds, H. Y., Fulmer, J. D., Kazmierowski, J. A., Roberts, W. C., Frank, M. M., & Crystal, R. G. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108615 · Cited by 557
Developmental and maturational changes in human blood lymphocyte subpopulations
Hannet, I., Erkeller-Yuksel, F., Lydyard, P., Deneys, V., & DeBruyère, M. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90157-3 · Cited by 407
Bronchoalveolar Lavage in Interstitial Lung Disease
WEINBERGER, S. E., KELMAN, J. A., ELSON, N. A., YOUNG, R. C., REYNOLDS, H. Y., FULMER, J. D., & CRYSTAL, R. G. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-4-459 · Cited by 293 · cited 1×
“[10] demonstrated that patients with IPF have increased numbers of neutrophils.”
BackgroundHaslam, P. L., Turton, C. W., Lukoszek, A., Salsbury, A. J., Dewar, A., Collins, J. V., & Turner-Warwick, M. (1980) · Thorax · doi:10.1136/thx.35.5.328 · Cited by 249 · cited 1×
“[11] reported a slight but significant increase in lymphocytes in patients' BAL fluid.”
BackgroundScott, J., Johnston, I., & Britton, J. (1990) · BMJ · doi:10.1136/bmj.301.6759.1015 · Cited by 221 · cited 1×
“Similar results were found in a case control study of causes of cryptogenic fibrosing alveolitis where smoking history was not related to the disease state [21].”
ResultDeterminants of progression in idiopathic pulmonary fibrosis.
Schwartz, D. A., Van Fossen, D. S., Davis, C. S., Helmers, R. A., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306043 · Cited by 156 · cited 2×
“In addition to thin-section CT [25], 67Ga lung scanning [26] and exercise testing [23] have been used to predict the progression of disease.”
MethodResult
Cited by
Molecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
“In patients with IPF, the presence of T cells within lung tissue and BAL of patients has been consistently observed [129-134].”
BackgroundThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“T Lymphocytes Relative to samples obtained from normal individuals, lung tissue and BAL fluid from patients with IPF are enriched for several population of T lymphocytes (126).”
BackgroundSavin, I. A., Zenkova, M. A., & Sen’kova, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314959 · Cited by 279
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
“1983], although lymphocytosis in patient samples is often associated with milder disease [Fireman et al. 1998; Watters et al. 1987; Rudd et al. 1981].”
BackgroundPulmonary fibrosis: from pathogenesis to clinical decision-making
Koudstaal, T., Funke-Chambour, M., Kreuter, M., Molyneaux, P. L., & Wijsenbeek, M. S. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.010 · Cited by 256
Metadata
- Authors
- Fireman, E., Vardinon, N., Burke, M., Spizer, S., Levin, S., Endler, A., Stav, D., Topilsky, M., Mann, A., Schwarz, Y., Kivity, S., & Greif, J.
- Affiliations
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Wolfson Medical Center (IL)
- Shmuel Harofeh Hospital (IL)
- Assaf Harofeh Medical Center (IL)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 1998-03-01
- Volume
- 11
- Issue
- 3
- Pages
- 706-711
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2120993895
- Cited by
- 64
- References
- 31
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 3 · 2020: 3 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 1 · 2013: 1 · 2012: 4
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- idiopathic pulmonary fibrosis, T cell subsets, CD4/CD8 ratio, cytotoxic T lymphocytes, bronchoalveolar lavage, neutrophils, corticosteroid therapy response, disease prognosis, immune homeostasis, lung function decline, disease progression prediction
- MeSH terms
- Bronchoalveolar Lavage Fluid, Cell Count, Cell Separation, Female, Flow Cytometry, Follow-Up Studies, Glucocorticoids, Humans, Male, Middle Aged, Predictive Value of Tests, Prednisone, Pulmonary Fibrosis, Respiratory Function Tests, Time Factors, T-Lymphocyte Subsets, CD4-CD8 Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1183/09031936.98.11030706
- The paper
- Fireman, E., Vardinon, N., Burke, M., Spizer, S., Levin, S., Endler, A., Stav, D., Topilsky, M., Mann, A., Schwarz, Y., Kivity, S., & Greif, J. (1998). Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. European Respiratory Journal. https://doi.org/10.1183/09031936.98.11030706
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.